2024-12-05 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Review

**1. Performance Comparison & Divergence:**

UnitedHealth Group (UNH) significantly outperformed the S&P 500 (VOO) over the analyzed period.  The cumulative return for UNH is 207.73%, while VOO's is 129.75%. This represents a difference of 77.98%.  The provided relative divergence of 49.2% indicates that UNH's outperformance is in the upper half of its historical range relative to the S&P 500.

**Company Overview:** UnitedHealth Group Inc. is a diversified healthcare company offering a range of health insurance and related services.


**CAGR, MDD, Alpha, Beta Analysis:**

The table shows strong Compound Annual Growth Rates (CAGR) for UNH across various periods, ranging from 24% to 113%.  Maximum Drawdowns (MDD) are relatively low, except for the 2020-2022 period (103%).  The Alpha consistently shows 0.0, indicating that UNH’s performance is largely explained by market movements (Beta).  Market capitalization has steadily increased.


**2. Recent Price Movement:**

* **Closing Price:** 605.23
* **5-Day Moving Average:** 607.82
* **20-Day Moving Average:** 600.83
* **60-Day Moving Average:** 585.63

The price is slightly below the 5-day moving average, suggesting some recent downward pressure. However, it remains above both the 20-day and 60-day moving averages, indicating a relatively positive longer-term trend.  The Last-market price of 609.72 suggests a minor uptick since the closing price used in the moving average calculations. This difference isn't significant enough to indicate a sharp rebound.


**3. Technical Indicators & Expected Return:**

* **RSI (Relative Strength Index):** 45.04 – Suggests the stock is approaching oversold territory, but not definitively so.
* **PPO (Price Oscillator):** 0.10 – A slightly positive value, indicating a potential bullish momentum.
* **Delta_Previous_Relative_Divergence:** NaN (-) –  Indicates a recent short-term relative underperformance.
* **Expected Return:** 175.4% – This represents a substantial projected outperformance compared to the S&P 500 over a long-term (2+ years) investment horizon.  This figure should be viewed cautiously as it's a projection, not a guaranteed outcome.


**4. Recent Earnings Analysis:**

The earnings data shows significant variability in EPS and a generally increasing revenue trend.

* **Latest Quarterly Results:**  The most recent quarter (2024-11-04) shows a strong EPS of 6.56, a significant improvement compared to the previous quarter's negative EPS (-1.53).  Revenue remains consistently high.  There is a duplicated entry for 2024-11-04, so there's no way to definitively state whether the 6.31 entry is a genuine repetition or a reporting error.
* **Revenue Growth:** Revenue has generally increased over the period shown, with some minor fluctuations.
* **EPS Trends:** EPS shows substantial volatility, highlighting the risk and reward associated with the stock.
* **Beats/Misses:** Without providing expected EPS figures, it's impossible to definitively state whether the results beat or missed expectations.


**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue has remained relatively stable, hovering around $98 Billion.  Profit margins have shown some fluctuation but have generally remained strong, above 20%.
* **Capital and Profitability:** Equity shows growth, though it fluctuates. Return on Equity (ROE) has also been volatile, ranging from a loss (-1.63%) to above 6%.  This suggests some vulnerability in profitability.

**6. News and Recent Issues:**  This section requires access to real-time news sources to provide current information on earnings announcements, market outlook, and analyst opinions within the last two days.

**7. Overall Analysis:**

UNH has shown a strong historical performance, significantly outperforming the S&P 500.  However, recent financial reports show volatility in EPS, suggesting some risk. The high expected return is promising for long-term investors, but it's crucial to consider the inherent risks in the healthcare sector and the variability in UNH's financial performance. The current price is near its moving averages, indicating neither a strong uptrend nor a strong downtrend.  Further research, including reviewing recent news and analyst opinions, is recommended before making any investment decisions. Technical indicators offer mixed signals.  The substantial historical outperformance should be viewed in light of the recent volatility in earnings.

**8. Disclaimer:** This analysis is based solely on the provided data and does not constitute financial advice.  Conduct thorough independent research and consult a financial advisor before making any investment decisions.  The provided expected return is a projection and should not be considered a guarantee of future performance.
